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Received 10 October 2014; revised 11 October 2014; accepted 30 October 2014AbstractTo gain insights into the ototoxic effects of aminoglycoside antibiotics (AmAn) and delayed peripheral ganglion neuron death in the inner
ear, experimental animal models were widely used with several different approaches including AmAn systemic injections, combination treat-
ment of AmAn and diuretics, or local application of AmAn. In these approaches, systemic AmAn treatment alone usually causes incomplete
damage to hair cells in the inner ear. Co-administration of diuretic and AmAn can completely destroy the cochlear hair cells, but it is impossible
to damage the vestibular system. Only the approach of AmAn local application can selectively eliminate most sensory hair cells in the inner ear.
Therefore, AmAn local application is more suitable for studies for complete hair cell destructions in cochlear and vestibular system and the
following delayed peripheral ganglion neuron death. In current studies, guinea pigs were unilaterally treated with a high concentration of
gentamicin (GM, 40 mg/ml) through the tympanic membrane into the middle ear cavity. Auditory functions and vestibular functions were
measured before and after GM treatment. The loss of hair cells and delayed degeneration of ganglion neurons in both cochlear and vestibular
system were quantified 30 days or 60 days after treatment. The results showed that both auditory and vestibular functions were completely
abolished after GM treatment. The sensory hair cells were totally missing in the cochlea, and severely destroyed in vestibular end-organs. The
delayed spiral ganglion neuron death 60 days after the deafening procedure was over 50%. However, no obvious pathological changes were
observed in vestibular ganglion neurons 60 days post-treatment. These results indicated that a high concentration of gentamycin delivered to the
middle ear cavity can destroy most sensory hair cells in the inner ear that subsequently causes the delayed spiral ganglion neuron degeneration.
This model might be useful for studies of hair cell regenerations, delayed degeneration of peripheral auditory neurons, and/or vestibular
compensation. In addition, a potential problem of ABR recording for unilateral deafness and issues about vestibular compensation are also
discussed.
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Loss of sensory hair cells and their connecting neurons in
the inner ear often leads to permanent hearing loss and/or
vestibular disorders. Although permanent hearing loss and
vestibular dysfunction are not life threatening, the quality of
life will be heavily influenced by the permanent disability.
Since the destruction of sensory hair cells and peripheral
ganglion neurons in the inner ear are unrepairable because they Head and Neck Surgery. Production and hosting by Elsevier (Singapore) Pte
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regenerate, it is difficult to rescue the sensorineural hearing
loss and balance dysfunction. The cochlear implant is widely
applied in clinic for profound deafness patients to bypass the
dysfunctional cochlea and to substitute for the missing hair
cells. The cochlear implant provides electrical signals to spiral
ganglion neurons and their axons projecting to the cochlear
nucleus. Therefore, sufficient spiral ganglion neuron survival
is a fundamental prerequisite for efficient work of cochlear
implant (Shibata et al., 2011; Pfingst et al., 2011). Thus, there
is a strong clinical need for establishing ways of promoting
spiral ganglion neuron survival following hair cell death.
Kanamycin or gentamicin selectively destroys sensory hair
cells in the inner ear followed by a slow progress of secondary
damage to spiral ganglion neurons due to the lack of electrical
stimulation and neurotrophic factors. This secondary degen-
eration of spiral ganglion neurons is referred to as “delayed
spiral ganglion neuron death” (Ding and Salvi, 2005;
McFadden et al., 2004; Ding et al., 2010a). In order to bet-
ter understand the interdependence of sensory hair cells and
peripheral ganglion neurons in the inner ear, as well as the hair
cell death pathways, hair cell regeneration, or delayed spiral
ganglion neuron death, numerous animal deafing models have
been studied in the field of hearing research. The studies
would benefit by the use of animal models with well-defined
cell damage in the inner ear.
Cochlear and vestibular hair cell damage can be induced by
numerous factors, such as acoustic trauma, aging, ototoxic
chemicals, blast wave, irradiation, infection, heavy metals,
pesticide, herbicide, organic solvent, and gene mutations, etc
(Ding and Salvi, 2005; Ding et al., 2012, 2011a, 2011b, 2004,
2010b, 2007; Ding et al., 1999a; Ding et al., 2002a, 2013,
2011c, 1999b; McFadden et al., 1999; Qi et al., 2008; Wang
et al., 1999; Wu et al., 2011a, 2011b; Someya et al., 2009;
Nicotera et al., 2004; Kane et al., 2012; Guan, 2011;
Federspil et al., 1976). These various aetiologies have led to
many attempts to develop appropriate animal models for
different study purposes. Since the ototoxic effects and
neurotoxic effects are presented together in most toxic
chemicals, such as platinum-based antineoplastic drugs, anti-
malarial drugs, and heavy metals, those chemicals should not
be used for the study of delayed neuron death. However,
aminoglycoside antibiotics such as kanamycin or gentamicin
directly destroy sensory hair cells while preserving the gan-
glion neurons in the inner ear during its injury, although the
spiral ganglion neurons finally will indirectly afterwards.
Therefore, kanamycin or gentamicin-induced direct injury to
sensory hair cells in the inner ear is considered an ideal
experimental models of delayed spiral ganglion neuron death.
In order to establish the experimental model of sensory
hair cell damage and delayed neuron death, several strategies
or approaches were attempted. One approach is systemic
treatment of kanamycin or gentamicin using consecutive
daily doses, because a single dose failed to induce inner ear
damage due to obstruction of the blood-labyrinth barrier,
except in the case of acute renal failure or genetic defects
(Guan, 2011; Federspil et al., 1976). Continued kanamycinor gentamicin systemic treatment for several days often
causes severe but incomplete damage to the cochlear hair
cells and vestibular hair cells (Ding and Salvi, 2005). To
overcome the obstruction of the blood-labyrinth barrier and
enhance the entry of ototoxic drugs into the inner ear, loop-
inhibiting diuretics, such as ethacrynic acid or furosemide,
which can abolish the blood flow in vessels supplying the
lateral wall of the cochlea and damage the stria vascularis,
temporarily open the bloodecochlear barrier thereby
enhancing the entry of ototoxic drugs into the cochlea (Ding
and Salvi, 2005; McFadden et al., 2004; Ding et al., 2010a,
2011a, 2004, 2010b, 2007, 2002a; Ding et al., 2003; Li
et al., 2011; Liu et al., 2011; McFadden et al., 2002). Co-
administering loop diuretics with kanamycin or gentamicin
can result in a complete hair cell loss in the cochlea, but
cannot injure the vestibular hair cells (Ding and Salvi, 2005;
Ding et al., 2010a, 2004; Liu et al., 2011; McFadden et al.,
2002; Ding et al., 1995). Therefore, this approach is only
able to wipe out all hair cells and allowing for the study of
delayed spiral ganglion neurons death in the cochlea. To
destroy the sensory hair cells in both the cochlear and
vestibular system while bypassing the blood-labyrinth bar-
rier, an alternative approach for gentamicin ototoxicity is via
the round window membrane which is permeable to many
agents (Ding and Salvi, 2005; Ding et al., 2011a; He et al.,
2009), or direct delivery into the cochlear or vestibular
cavity (Li et al., 2004; Swan et al., 2008; Wagner et al.,
2005). Since the local application of gentamicin by tym-
panic injection is simple and effective to damage both
cochlear and vestibular sensory hair cells, we applied
gentamicin to one ear to create a unilateral loss of sensory
hair cell loss in both the cochlear and vestibular system. The
functional and pathological changes in the cochlear and
vestibular system were observed after gentamicin treatment,
and the delayed peripheral ganglion neurons degeneration
was also evaluated.
2. Materials and methods2.1. Animal treatmentTwenty 250e300 g adult pigmented guinea pigs with
normal Preyer's reflexes were used in the present study. Ani-
mals were anesthetized with a mixture of ketamine (30 mg/kg
i.p.) and chloropromazine (15 mg/kg, i.p.), and placed on a
temperature-controlled heating pad with a rectal probe to
maintain core temperature at 37 C. Guinea pigs were placed
in a right lateral position, and the left meatus of the external
ear was sterilized by filling with 70% ethanol for 5 min. The
meatus of the external ear was then dried by aseptic cotton
swab. Under a surgical microscope and sterile conditions,
approximate 200 ml gentamicin sulfate dissolved in normal
saline at a concentration of 40 mg/ml in 1 ml syringe was
penetrated through tympanic membrane, and slowly injected
into the middle ear cavity until the solution completely filled
the middle ear cavity and overflowed into the external ear
canal as described previously (He et al., 2009).
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placed in a lateral position with the treated ear upward,
until animals wakened from the anesthesia so that any air
bubbles in the irregularly shaped lacunae in the middle ear
cavity would float out of the round window niche. In each
animal, the left ear was administrated with gentamicin and
the right ear was injected with saline as self-control ear.
The functional and morphological analysis in both cochlear
and vestibular systems were investigated, and the delayed
ganglion neuron death in both cochlear and vestibular
system was also assessed 30 days and/or 60 days after GM
treatment respectively.
All animals were purchased from Experimental Animal
Center of Xiangya Medical College, Central South University
and all experimental procedures regarding animal care and use
were approved by the Institutional Animal Care and Use
Committee of Xiangya Medical College.2.2. Evaluation of hearing functionThe procedures for measuring the auditory brainstem
response (ABR) and cochlear compound action potential
(CAP) have been described in our previous publications (Ding
et al., 2002a, 1999b; Wu et al., 2011a; Kane et al., 2012; Ding
et al., 2003; Li et al., 2011; Ding and Jin, 1998; Ding et al.,
1993, 1996; Wang et al., 1996; Ding and Zhang, 1995).
Each animal was tested before drug treatment and on the day
of termination. Animals were anesthetized as described above
and the body temperature was maintained at 37 C using a
heating pad. Testing was performed in a sound-isolated and
electrically-shielded booth. For ABR measurement, three
recording electrodes were inserted subcutaneously at the ver-
tex and at both mastoids respectively. The responses were
recorded and processed by TDT system III (TDT, USA). The
ABR was elicited with tone bursts at 1, 2, 4, 8, 12, 16 kHz.
Stimuli were generated digitally with 3 ms duration, 0.5 ms
rise/fall time, alternating phase, repeated at 21/s, and fed to a
magnetic speaker (MF1, TDT, USA) located 10 cm in front of
the test ear. Evoked potentials were filtered between 100 and
3000 Hz, and averaged 512 times. The thresholds were ob-
tained by reducing the sound intensity in 5 dB increments
from 90 dB SPL to below the intensity where the ABR dis-
appeared. The ABR threshold was defined as the lowest in-
tensity capable of eliciting a replicable, visually detectable
response. The CAP was recorded from facial canal by a thin
recording electrode. As described previously (Ding and Jin,
1998; Ding et al., 1993, 1996; Wang et al., 1996; Ding and
Zhang, 1995). In brief, a surgical incision was made at the
postauditory process to expose the facial nerve. After
removing the facial nerve from the facial canal, a Teflon-
coated sliver recording electrode was gradually insert into
the facial canal until the horizontal segment of facial canal,
which is just separated from cochlea by a very thin bony wall.
Afterwards, the facial canal was closed with dental cement and
the incision was sutured. The sound stimuli used to elicit the
CAP were basically the same as for the ABR recording, except
the CAP was averaged 100 times.2.3. Evaluation of vestibular functionThe procedures for measuring the vestibular nystagmus
response (VNR) and the swimming test (ST) have been
described in our previous publications (Ding et al., 1999b,
1997; Li et al., 2004; Zhou et al., 2009). To evaluate the
duration of the VNR, the guinea pig was restrained in a
custom holder. After irrigating the external ear canal with
0.5 ml of 0 C water, the head of guinea pig was fixed in a
position in which the lateral semicircular canal was ori-
ented vertically to the ground. The VNR duration was
recorded visually with a stopwatch. In addition, animal
balance behavior was also observed during the ST. Ani-
mals were placed into a pool filled with warm water for
about one minutes to determine if the animal could swim
or roll over in the water (Zhou et al., 2009).2.4. Histological analysis
2.4.1. Cochlear and vestibular hair cell evaluation
After animals were anesthetized and decapitated, cochlea
were removed immediately from temporal bones. The inner
ear cavity was opened and the otolithic membrane in the
saccule and utricle were removed. Then cochlea were perfused
with 0.5% silver nitrate solution and then fixed with 4%
formaldehyde overnight at 4 C. Following fixation, the basilar
membrane and the end organs of the vestibular system
including the macula of the utricle and saccule, ampullary
cristae of the three semicircular canals were carefully
dissected out under an anatomical microscope and processed
for flat surface preparation (Ding et al., 1999b, 2003; Li et al.,
2004; Ding et al., 1989, 2001, 1981, 1986, 1987). To quantify
hair cell loss, surface preparations of the cochlear basilar
membrane were examined with a light microscope (Zeiss,
Germany). Hair cells were counted over a 0.24 mm interval
along the entire organ of Corti as described previously (Ding
and Salvi, 2005; Ding et al., 2011a, 2011b, 2013, 1999b;
McFadden et al., 1999; Qi et al., 2008; Wang et al., 1999;
Kane et al., 2012; Ding et al., 2003; Li et al., 2011; Liu
et al., 2011; McFadden et al., 2002). The cochleogram
showing the percent hair cell loss as a function of the percent
distance from cochlear apex was constructed using custom
cochleogram software. A laboratory norm of hair cell number
for young normal guinea pigs was used as a reference to
calculate percent of hair cell loss. To compare the data, indi-
vidual cochleograms were aggregated to produce a mean
cochleogram for each group. The flat surface preparations of
the vestibular end organs were also observed under the light
microscope and photographed. To quantify the level of hair
cell loss, the number of hair cell in each vestibular end-organ
was counted in several regions of each sample. The hair cell
density was obtained and stored in a personal computer for
further analysis using Image J software (NIH, USA). Hair cell
density measurements were made from three to five regions of
each specimen and a mean value was computed for each
specimen as described previously (Ding and Salvi, 2005; Ding
et al., 2011a, 2011b, 2013, 1999b; McFadden et al., 1999; Qi
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2003; Li et al., 2011; Liu et al., 2011; McFadden et al., 2002).2.5. Quantification of cochlear and vestibular ganglion
neuronsFig. 1. Changes of hearing response in saline treated ears and GM treated ears.
(A) Normal ABR waveforms were seen 30 days after saline treatment. (B)
ABR waveforms 30 days post-GM. Note that the threshold of ABR was just
elevated about 20 dB likely due to acoustic cross over to the better saline-
treated ear. (C) Normal CAP waveforms were detected 30 days after saline
treatment. (D) CAP waveforms were missing 30 days post-GM, but in contrast
to the ABR. (E) Mean CAP thresholds in saline control group and GM treated
group 30 days after treatment. CAP threshold were not detectable in the GM
treated ears at all tested frequencies. Up arrows on GM treated ears indicate
that the thresholds of CAP exceded the highest intensity of sound stimulus at
90 dB SPL (mean ± SD, n ¼ 12 ears per group).The temporal bone was obtained as described above and
fixed with 2.5% glutaraldehyde in 0.1 M phosphate buffer (pH
7.2) overnight at 4 C. The temporal bone was decalcified in
3% hydrochloric acid at room temperature for 3 days. After-
wards, specimens were further fixed with 2% osmium for 2 h
and then dehydrated with gradient alcohol and acetone series.
Afterwards, specimens were immersed in acetone and Epon
812 mixture at a ratio of 1:1 overnight. Finally specimens were
embedded in Epon 812 at 60 C for polymerization. The
specimens were then sectioned serially at a thickness of 4 mm
in the horizontal plane parallel to the cochlear modiolus using
a microtome. Sections were collected on glass slides, and
stained with toluidine blue. All sections were examined under
the light microscope (Zeiss, Germany) and photographed
(McFadden et al., 2004; Someya et al., 2009; Kane et al.,
2012; Li et al., 2011; Ding et al., 1993, 1997, 2002b, 1998).
The densities of spiral ganglion neurons (SGN) in each turn of
the cochlea and the superior and posterior vestibular ganglion
neurons (VGN) were quantified using image J software as
described previously (Ding et al., 1998, 2002c). The bound-
aries of Rosenthal's canal were outlined and its cross-sectional
area was calculated. The number of SGN in each canal was
counted, and the density of SGN was computed by dividing
the number of SGN by the canal cross-sectional area. The
pathological changes and the density of superior and inferior
VGN were also evaluated. To avoid double counting, every
fifth section was selected for cell counts. Only SGN and VGN
with a clear nucleus and nucleolus were counted.2.6. Statistical analysisAll statistical analyses were carried out by t-test and one-
way ANOVA followed by NewmaneKeuls post hoc analyses
using the GraphPad Prism5 software. All tests were two-sided
with the threshold for statistical significance set at P < 0.05.
3. Results3.1. Changes of hearingPrior to the transtympanic application of gentamicin or
saline, tone bursts at 1, 4, 8, 16 kHz elicited ABR thresholds
were in a range of 20e40 dB SPL across all tested fre-
quencies. There was no significant difference between the left
ear and the right ear in the pretesting (t test, P > 0.05). On the
day of termination, auditory function was tested again by ABR
and CAP respectively. The ABR responses for both ears (right
ears were saline control, left ear were treated by GM) were all
detectable, and only small threshold elevations were observed
in the GM treated ear due to bone conduction cross over to
control ear (Fig 1 A and B). In contrast, the results obtainedfrom CAP were different to those obtained from ABR mea-
surement. The CAP thresholds in saline control ear were very
similar to the ABR thresholds in all guinea pigs (t test,
P > 0.05). However, CAP responses were undetectable in GM
treated ear, unlike wave forms of ABR which may suggest the
ABR reflections from contralateral ear, the saline control ear
(Fig. 1C, D, E).3.2. Cochlear hair cell missingTypical surface views of the basilar membrane and mean
cochleogram from saline control ears and GM treated ears are
shown in Fig. 2. 30 days after treatment, both outer hair cells and
inner hair cells in GM treated ears were completely missing
along the entire basilar membrane, which is consistent with the
CAPabsence. In contrast, all hair cells in control earswere intact
(Fig. 2A, B, C). Cochlear sections similarly show that the organ
of Corti in each turn was completely collapsed in GM treated
ears. However, the organ ofCorti was normal in all saline control
ears (Fig. 3). In a total of 14 examined GM treated ears, only a
very inner hair cells weer detected in the apical turn in two an-
imals, while all hair cells through the entire length of the cochlea
were totally absent in the remaining ears treated with GM.3.3. Balance dysfunctionTo estimate the changes of vestibular function, the duration
of the VNR was examined before and 30 days after GM
Fig. 2. Cochlear hair cell loss. (A) Representative surface preparation of cochlear basilar membrane from saline treated ear. Note all inner hair cells and outer hair
cells were intact. (B) Representative surface preparation of cochlear basilar membrane from GM treated ears 30 days after treatment. Note all sensory hair cells
were completely destroyed. (C) Mean cochleogram shows nearly 100% hair cells were missing in GM treated ears along the enter length of the cochlea. In contrast,
no cochlear hair cell missing in saline treated ears (N ¼ 5 for each condition).
130 J. Yu et al. / Journal of Otology 9 (2014) 126e135treatment. Fig. 4A shows the average duration of the VNR
before and 30 days after GM administration. In pretesting, the
duration of the VNR was 48.80 ± 11.81 s. However, the VNR
response completely disappeared 30 days after GM treatment.
In addition, we also found that guinea pigs exhibited obvious
head tilt in the direction of GM treated ear about 2e3 days
after treatment (Fig. 4B). However, a progressive recovery ofFig. 3. Representative images of cochlear sections for a saline treated ear and a G
ganglion neurons and auditory nerve fibers in Rosenthal's canal were normal in s
ganglion neurons and nerve fibers in Rosenthal's canal were also diminished in GM
middle turn, D and H: basal turn).head position was observed afterwards. The head position was
nearly normal 10e15 days after treatment. Guinea pig main-
tained normal body balance in the water in pretesting. How-
ever, after GM local application, animals showed obvious
balance dysfunction that involved rolled over in the water
(Fig. 4C, D).M treated ear respectively. (AeD) The organ of Corti in each turn and spiral
aline treated ear. (EeH) All hair cell were missing and the density of spiral
treated ear. (A and E: apical turn, B and F: upper middle turn, C and G: lower
131J. Yu et al. / Journal of Otology 9 (2014) 126e1353.4. Vestibular hair cell lossVestibular hair cell damage was assessed 30 days after
treatment. A typical surface preparation view from the macula
of the utricle in a saline control ear and a GM treated ear were
as shown in Fig. 5A and B respectively. The cuticular plate of
hair cells was clearly visible with high cell density in the sa-
line treated ear, but most hair cells were missing in the GM
treated ear (Fig. 5A, B). Quantitative analysis of hair cell
density in the macula of the saccule, macula of the utricle and
the three crista ampullaris showed that the hair cell density in
GM treated ears was greatly reduced in comparison with sa-
line control ears. Significant difference in hair cell density of
vestibular end-organs was detected between the saline control
ears and GM treated ears (one-way ANOVN, P < 0.01)
(Fig. 5C, D).3.5. Delayed SGN destructionThe density of SGN in Rosenthal's canal in each turn was
counted and compared between saline treated ears and GM
treated ears 30 days and 60 days after treatment respectively.
In saline treated control ears, SGN and auditory nerve fibers in
Rosenthal's canal were densely packed, while in GM treated
ears, SGN and auditory nerve fibers were greatly reduced,
especially 60 days post-GM (Fig 6). Compared with control
cochleae, the density of SGN began to decrease about 20%
across the entire cochlea in each turn 30 days after GM
treatment (NewmaneKeuls test, P < 0.01). In contrast, more
than 50% of SGNs were missing 60 days after GM treatment
(NewmaneKeuls test, P < 0.01) (Fig 7).3.6. Delayed VGN destructionWhether it was 30 days or 60 days after treatment, the
histology and morphology of VGN in both saline treated earsFig. 4. Vestibular dysfunction. (A) Mean duration of VNR in pretesting was ab
(mean ± SD, n ¼ 10 ears per group). (B) Experimental guinea pigs showed obvious
comparison with normal animal (right). (C) In swimming test, normal orientation wa
was severely disrupted in unilateral ear damage 30 days post-GM.and GM treated ears were still present and normal (Fig. 8A,
B). There was no significant statistical difference in VGN
density between saline treated ears and GM treated ears
(Fig. 8).
4. Discussion4.1. Complete hair cell damage by GM local applicationStudies with the aim of understanding the mechanisms of
hearing loss and vestibular dysfunction can be greatly aided by
animal models in which cells lesion occurs in well-defined
patterns. In the current study, we found that intratympanic
delivery of a single high dose of GM resulted in a permanent
hearing loss and severe vestibular dysfunction which were
confirmed by almost total sensory hair cell loss in both the
cochlear and vestibular system. The results demonstrate that
GM effectively infiltrated into the inner ear via the round
window membrane which successfully avoided the obstacles
of the blood-labyrinth barrier. Usually there are two ways to
deliver chemicals on the round window membrane. One
approach is to place a small amount of chemical solution about
20 ml on the round window niche; however, with is method it
is difficult to cause complete destruction of all sensory hair
cells in the inner ear (He et al., 2009; Ding et al., 1989).
Another approach is intratympanic injection to fill up the
middle ear cavity with GM solution which is not only simple,
but also very effective, because the large GM solution is
present for a longer period, enough to destroy most hair cells
in the inner ear. This is consistent with previous reports
showing that a single intratympanic dose of GM can induce a
rapid GM accumulation with a high peak value in the fluid of
the inner ear that last for 24 h at least, which is sufficient to
induce a massive hair cell loss (He et al., 2009; Ding et al.,
1989). In addition, intratympanic GM enters the cochlea by
diffusion through the round window membrane that enters intoout 50 s, while 30 days after GM treatment, VNR was completely absent
head tilt in the direction of GM treated ear (left) 2 days after GM treatment in
s detected in normal animals before the experiment. (D) Swimming orientation
Fig. 5. Density of hair cells in vestibule-end organs. (A) Surface review of macula of utricle showing sensory hair cell survival in saline treated ear. (B) Massive
hair cell loss was found in the macula of utricle from GM treated ear. (C) The hair cell density in macula of saccule and utricle in saline treated ears were compared
with GM treated ears. Note that the hair cell densities in macula of saccule and utricle were greatly reduced by GM treatment. (D) The hair cell density in crista of
ampulla in three semicircular canals in saline treated ears was compared with GM treated ears. Note that the hair cell densities in all crista of the ampulla was
significantly reduced. Data are expressed as mean ± SD, n ¼ 6 ears per group. * Significant difference from control (P < 0.01).
132 J. Yu et al. / Journal of Otology 9 (2014) 126e135the scala tympani first, subsequently the scala vestibule via the
helicotrema at the apex, and then into the vestibular cavity.
This long diffusion pathway causes more hair cell lesions in
the cochlea than the vestibular system. Therefore, longerFig. 6. Representative images showing the density of spiral ganglion neurons in Ro
portion of the cochlea are present and normal. (FeJ) 60 days after GM treatment thexposure of GM via round window membrane is needed to
establish all hair cell damage in the vestibular system (Li et al.,
2004; Wanamaker et al., 1998).senthal's canal. (AeE) 60 days after saline treatment, spiral ganglions at each
e density of spiral ganglion neurons in Rosenthal's canal was greatly reduced.
Fig. 7. Relative survival of SGNs in GM treated ears at different time points
normalized to saline control ears. Data are expressed as mean ± SD, n ¼ 6 ears
per group. * Significantly different from saline control at 60 days postesaline
(P < 0.01), # Significantly different from GM treated ears 30 days after
treatment (P < 0.01) (B1 ¼ lower basal turn, B2 ¼ upper basal turn,
M1 ¼ lower middle turn, M2 ¼ upper middle turn, A1 ¼ lower apical turn).
133J. Yu et al. / Journal of Otology 9 (2014) 126e1354.2. Delayed peripheral ganglion neuron degenerationThe delayed peripheral neuronal degenerations can be
attributed to the loss of sensory hair celleneuronal activity as
well as deficiency of neurotrophic factors by sensory hair cell
missing (Ding and Salvi, 2005; McFadden et al., 2004; Ding
et al., 2010a). Since the cochlear implants electrically stimu-
late residual SGNs to provide auditory signals to the auditory
center, therefore the functional ganglion neurons are crucial to
the successful use of cochlear implants. According to reports
in the literature, providing an exogenous supply of neuro-
trophins and/or chronic intracochlear electrical stimulation has
been shown to prevent SGN degeneration. To better under-
stand the process of delayed spiral ganglion neuron degener-
ation in experimental conditions, a complete hair cell missing
is needed as an ideal animal model. In current study, a single-
dose intratympanic GM successfully destroyed 100% cochlear
hair cells. After disappearance of cochlear hair cells, some
SGNs were missing 30 days post-GM treatment, and continue
progressive SGN degeneration was observed 60 days after
deafening procedure. These results are basically consistent
with previous studies showing that delayed SGN neuron death
is in a time-dependent manner (Ding and Salvi, 2005;
McFadden et al., 2004; Ding et al., 2010a; Versnel et al.,
2007). As to vestibular ganglion neurons, however, no
obvious degeneration was found by 60 days post-treatment in
current study, which is consistent with previous studies that the
VGN can be survival for a long period without vestibular hair
cells (Dupont et al., 1993). Once again, our findings indicated
that VGN can really survive longer than SGN after sensory
hair cell loss. In current study, at least two reasons account for
the VGN survival. One is the incomplete destruction of sen-
sory hair cells in vestibular end-organs. The remained few
survival vestibular hair cells can still supply signal stimula-
tions and neurotrophic factors to VGN, which may be barely
adequate to maintain the vestibular neurons survival. Another
reason is that VGN may receive electric stimulations or neu-
rotrophins from an unknown source which may be differentfrom those of SGN. This unbeknown region definitely needs to
be further studied.4.3. Potential problems from ABR recordingAuditory brainstem response (ABR) is an auditory evoked
potential, widely used to test the hearing function in clinic and
experimental animal models. It can be recorded via electrodes
placed on the scalp by the computer averaging technology (Wu
et al., 2011a; Kane et al., 2012; Wang et al., 1996; Jewett et al.,
1970; Starr and Achor, 1975). ABR is usually detected in the
first 10ms followingacoustic stimuliwith several typical repeated
waves. Thewave I ofABR is generated by auditory nerve, and the
following wave II, III, IV, and V are generated by cochlear nu-
cleus, superior olivary complex, lateral lemniscus, and inferior
colliculus, respectively. Therefore, wave III and the following
waves are actually reflecting the activity in central components of
the auditory pathway by hearing signal input from both ears.
Although the sound stimuli can be towards one ear for ABR
testing, the sound can be listened with both ears. In clinic mea-
surement of hearing bymeans of an audiometer, if there is a 30dB
hearing difference between the two ears, a sound masking is
needed to cover up the normal ear, otherwise the real hearing
response from deaf ear will be difficult to evaluate. In the
experimental animal, such as guinea pig which has a small head
that the sound is even easier to conduct to contralateral ear. In our
previous study, we have demonstrated that the ABR threshold
was similar between the two ears fromunilateral deaf guinea pigs
(Wang et al., 1996). Consistently, all experimental animals in
current study have complete deafness and hair cell loss in one ear.
However, ABR can still be detected from these completely
deafened ears (Fig. 1). These findings may indicate that ABR
results can be confused by signals from the contralateral normal
ear in unilateral deafened animal. Another interesting finding
from current study is that the CAP recording from the deaf ear
actually elicited the ABR wave without wave I and wave II. This
suggests strongly that the electrode in the facial canal can receive
hearing signals from auditory pathway in brain stem by opposite
normal ear, if the testing earwas deaf. It once again proves that the
ABR is inapplicable to unilateral deafness unless the contralateral
normal ear was covered up by sound masking.4.4. About vestibular compensationUnilateral destruction of vestibular system always leads to a
syndrome of postural and oculomotor disorders in rodents due to
the disruption of central vestibulo-ocular and vestibulo-spinal
pathways (Zhou et al., 2009, 2013; Deveze et al., 2014). How-
ever, many of these deficits gradually subside in a process of
behavioural recoverywith the passage of time,which is described
as “vestibular compensation” (Zhou et al., 2013;Darlington et al.,
1991). In the present study, we also noted this phenomenon in
unilateral vestibular destruction in guinea pigs. As mentioned in
the results, around 2e3 days after GM treatment, animals
exhibited obvious head tilt in the direction of non-functioning ear.
Then, animal head gradually recovered to the normal position by
10e15 days after treatment. Although the balance function of
Fig. 8. Vestibular ganglion neurons (VGN) in saline and GM treated ears 60
days after treatment. (A) VGN present normal in saline control ear. (B) The
appearance of VGN in GM treated ear was intact. (C) No significant difference
was detected in VGN density between saline and GM treated ears (mean ± SD,
n ¼ 6 ears per group).
134 J. Yu et al. / Journal of Otology 9 (2014) 126e135these animals with unilateral vestibular dysfunction appears
normal on the ground, however, when animals were placed into
the water under buoyancy environment for swim test, all tested
guinea pigs had significant balance dysfunction in water which
rolled over towards the direction of non-functioning ear. This is
consistent with our previous findings in unilateral destruction of
vestibular system by carboplatin local application (Zhou et al.,
2009). The findings indicated that despite the vestibular
compensation can be occurred on land, while the defect of
vestibular disorders had no opportunity to be acclimatization in
water for terrestrial animals. Therefore, the severe vestibular
dysfunctions present again in swimming test. Recently it has been
shown that the mechanism of vestibular compensation is mainly
attributed to the plasticity in the central nervous system (Ris et al.,
1995). However, aspects of the compensation process are still
poorly understood. Hence, our data may provide an ideal animal
model for the studies of vestibular compensation and related re-
organizations of central nervous system.
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